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A B S T R A C T
Halo nevi, also termed Sutton nevi, are defined as benign melanocytic nevi that are surrounded by an area of de-
pigmentation resembling a halo. Halo nevi are common in children and young adults, with a mean age at onset of 15
years. The incidence in the population is estimated to be approximately 1%. Affected individuals frequently have multiple
lesions which are usually localized on the back. A familial tendency for halo nevi has been reported. The etiology of halo
nevi is unknown. It is an autoimmune response and T lymphocytes are considered to play a key role in the progressive de-
struction of nevus cells. Halo nevi may be associated with autoimmune disorders such as vitiligo, Hashimoto thyroiditis,
alopecia areata, celiac disease, atopic dermatitis and others. It has been proved that halo nevi are detected after an in-
tense sun exposure especially after sunburns. The etiology of halo nevi, association with malignant melanoma and the
role of sun exposure in the development of halo nevi are discussed.
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Introduction
Halo nevi (HN), also termed leukoderma acquisitum
centrifugum or Sutton nevi, are defined as benign mela-
nocytic nevi that are surrounded by an area of depig-
mentation resembling a halo1,2. This phenomenon often
indicates the beginning of involution and subsequent re-
gression of the melanocytic nevus, a process that extends
over a period of several months or years3. The central ne-
vus may persist unchanged or become less pigmented
over time, but often the nevus involutes, leaving a local-
ized area of depigmented skin4,5. The localized area of
depigmentation may persist for months or years, or
repigment totally4,5.
HN is common in children and young adults, with a
mean age at onset of 15 years6. The incidence in the pop-
ulation is estimated to be approximately 1%6,7. Affected
individuals frequently have multiple lesions which are
usually localized on the trunk and back. A familial ten-
dency for halo nevi has been reported8.
The most frequent association of HN is vitiligo, with
vitiligo lesions appearing in nearby regions, as well as at
other sites9. HN may also be associated with autoim-
mune disorders such as Hashimoto thyroiditis, alopecia
areata, celiac disease, atopic dermatitis and others10,11.
The association with malignant melanoma has been re-
ported by a large number of authors12.
The prototype of halo lesion is classic HN. The halo
phenomenon may also be observed around other benign
or malignant lesions, such as blue nevus, Spitz nevus,
Mongolian spot, café au lait spot, neurofibroma, basal
cell carcinoma, seborrhoeic keratosis, dermatofibroma
and flat wart13. The halo phenomenon has been reported
in association with malignant melanoma as well13.
Halo Nevi, Etiology and UV Radiation
The etiology of the HN is unknown. It seems to occur
either following exposure to UV radiation, especially af-
ter sunburns13, 14 or most often idiopathically. Rarely, it
may occur following application of topical bleaching pre-
parations13.
UV light exposure, measured as amount of UV radia-
tion at the particular location or the amount of time
spent in the sun and sunburns before the age of 20 have
been associated with increased risk of melanoma, with
the development of multiple melanocytic nevi and clini-
cally atypical nevi15–18. Histological changes and higher
metabolic activity can be seen in UV-exposed nevi as a re-
sult of trauma-induced reparatory mechanisms19,20. These
molecular alterations could be antigen structures that
induce immune response20–22. Once the immune system
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has been stimulated, it recognizes simple antigens in
atypical and also in normal cells and that explains multi-
ple halo nevi in some individuals21,23.
The pathogenesis of the HN is also unclear. Histo-
pathologically HN is characterized by progressive degen-
eration and disappearance of the melanocytes, with in-
flammatory infiltrate composed mainly of T lymphocytes,
with prevalence of the cytotoxic CD 8+ subset3. These
data prove involvement of T-cell-mediated immune res-
ponse21. The influence of circulating antibodies as a sec-
ondary factor in immune elimination of nevus cells re-
mains a possibility21. Patients with HN very often have
circulating antibodies to cytoplasmic antigens in mela-
noma cells21 that disappear after excision or spontaneous
resolution of HN. These antibodies may occur after cell-
-mediated lysis of the nevus cells with release of the
nevocellular antigen that stimulates B-cells. Further-
more, activated CD4-positive helper T-cells may stimu-
late B-cells, via production and release of lymphokines,
to undergo differentiation with subsequent production of
a specific antibodies21–24.
Halo Nevi and Malignant Melanoma
There are many reports about the possible relation-
ship between HN, vitiligo or vitiligo-like leukoderma on
one hand and melanoma on the other12,25–28. Cutaneous
depigmentation and hypopigmentation have been fre-
quently reported during the course of malignant mela-
noma, such as regression of the primary malignant mela-
noma or its metastases, HN around melanocytic nevi and
vitiligo appearing in nearby regions or at sites distant
from malignant melanoma12,25–28. The halo phenomenon
has also been reported in association with malignant
melanoma and it is called halo melanoma13,29.
The development of different types of hypomelanosis
in association with malignant melanoma represents an
immunologic reaction, cellular and humoral, to the anti-
gens shared by normal melanocytes and melanoma
cells9,13,30,31. Malignant melanoma is a tumor that can
spontaneously regress and once the immune response is
stimulated, it recognizes common antigens in the malig-
nant cells and in the normal cells. The occurrence of
depigmentation in melanoma patients is commonly be-
lieved to be a positive prognostic factor, suggesting the
development of an antitumoral response32–34. However,
larger studies are needed to clarify if different types of
hypomelanosis represent a favourable sign in the course
of malignant melanoma.
Approach to Patients with Halo Nevi
Approaches to the management of HN in children dif-
fer from approaches in adult patients. In children and
young adults, HN are common, usually benign, symmet-
rical lesions and clinical observation over time is the best
policy. It is important to examine not only HN but whole
skin and visible mucus membranes. Multiple lesions in
children are common, so all patients with HN should be
examined with Wood’s filter. Children’s skin is pale and
multiple lesions are not necessarily seen with naked eye.
However, HN may be associated with other diseases, so
in children with multiple HN we recommend to do com-
plete blood count, antinuclear antibodies, screened for
thyroiditis and celiac disease. There is no need for treat-
ment in patients with solitary HN. Halo melanoma in a
child is extremely unusual and should be considered sus-
picious only if the halo is asymmetrical, or if the central
lesion is unusual35. Lai et all also suggest caution if the
nevus is congenital35. The »ABCD« diagnostic criteria for
melanoma are also applied to the central lesion of a halo
melanoma36. These include asymmetry, border irregular-
ity, colour variegation and diameter.
HN are uncommon in adults. A sudden onset of HN,
vitiligo or leukoderma in adult patients can be a reason
for paying more attention in the examination of other
melanocytic lesions25. If there is any doubt, clinicians
should perform an excision biopsy to obtain a histological
diagnosis. Halo melanoma and melanoma are more com-
mon in adults than in children.
Conclusions
There are many reports about the possible relation-
ship between HN, vitiligo and other forms of cutaneous
depigmentation and malignant melanoma. It is now
known that excessive exposure to sunlight early in life is
an important determinant in the later development of
malignant melanoma and such exposure may also be an
initiating factor in the development of HN. It is impor-
tant to emphasise that the majority of changes in pig-
mented skin lesions occur during childhood and adoles-
cence, so sun protection must start from the first days of
life37.
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»HALO NEVUSI« I UV ZRA^ENJE
S A @ E T A K
Halo nevusi, poznati i kao Sutton nevusi, su benigne melanocitne lezije okru`ene zonom depigmentacije-haloom.
Obi~no se javljaju u djetinjstvu i adolescenciji, naj~e{}e oko 15. godine `ivota. U op}oj populaciji javljaju se s inciden-
cijom od 1%. Lezije mogu biti pojedina~ne ili multiple, naj~e{}e lokalizirane na ko`i le|a. Opisana je i obiteljska pojava
halo nevusa. Iako se radi o dobro}udnim promjenama potreban je oprez jer se halo nevusi mogu pojaviti udru`eni s
malignim melanomom ~e{}e nego {to se prije mislilo te mogu predstavljati imunolo{ki odgovor na melanom. Etiopato-
geneza halo nevusa je nepoznata. Dokazano je da se radi o autoimuno pokrenutom odgovoru te da T limfociti imaju
glavnu ulogu u razaranju nevus stanica. ^esta je udru`enost halo nevusa s drugim bolestima naj~e{}e autoimunim
bolestima kao vitiligo, Hashimotov tiroiditis, alopecija areata, celijakija, atopijski dermatitis i druge. Potvr|ena je po-
java halo nevusa nakon intenzivnog izlaganja UV zra~enju, osobito nakon sun~anih opeklina. Prikazana je etiopato-
geneza halo nevusa, udru`enost halo nevusa i malignog melanoma te utjecaj UV zra~enja na nastanak halo nevusa.
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